Protara Therapeutic Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.27

-0.10 (-1.86%)

As of May 10, 10:26 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +344.8% upside

Low Target $15.10

Average Target $23.44

High Target $28.04

Current Price $5.27

Current
$5.27

Target
$23.44

$15.10 $23.44 avg $28.04

Scenario Analysis

Bear Case

$15.10

186.5%

Low target

Base Case

$23.44

+344.8%

Avg target

Bull Case

$28.04

+432.1%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.82

-32.6% from high

52-Week Low

$2.77

+90.3% from low

Target vs 52W High

$23.44

+199.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%